News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2021 Shelley Wood May 31, 2021
News Daily News Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care Shelley Wood May 27, 2021
News Daily News US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines Todd Neale May 24, 2021
News Conference News ACC 2021 Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs Todd Neale May 18, 2021
News Conference News ACC 2021 RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients Todd Neale May 17, 2021
News Conference News ACC 2021 Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients Shelley Wood May 16, 2021
News Conference News ACC 2021 PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI L.A. McKeown May 15, 2021
News Daily News New HF Uncommon After COVID-19, but Rare Cases Pose Quandary Shelley Wood April 28, 2021
News Daily News Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA Michael O'Riordan April 26, 2021
News Daily News New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research Michael O'Riordan April 23, 2021
News Daily News Pneumonia in HF Patients Is Common, Lethal, and Preventable L.A. McKeown April 19, 2021
News Daily News Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF Michael O'Riordan April 15, 2021
News Daily News Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms Michael O'Riordan April 02, 2021
News Daily News Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations Todd Neale March 04, 2021
News Daily News High Glycemic Index Diets Linked to CVD and Mortality Michael O'Riordan February 24, 2021
News Daily News Women’s Risk for CVD Seen at Lower BP Thresholds Than Men L.A. McKeown February 24, 2021